anastrozole
Showing 1 - 25 of 171
ive Alzheimer's Medicines- Anastrozole vs Exemestane/Letrozole
Active, not recruiting
- Breast Cancer
- Anastrozole
- Exemestane/Letrozole
-
Boston, MassachusettsBrigham and Women's Hospital
Dec 1, 2022
Klinefelter Syndrome Trial (Anastrozole, Semaglutide, human chorionic gonadotropin)
Not yet recruiting
- Klinefelter Syndrome
- Anastrozole
- +3 more
- (no location specified)
Oct 15, 2022
Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in
Terminated
- Estrogen Receptor-negative Breast Cancer
- +6 more
- entinostat
- +3 more
-
Baltimore, MarylandUniversity of Maryland Baltimore
Apr 29, 2022
Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Invasive Breast Cancer Trial in United States (drug,
Recruiting
- Early-stage Breast Cancer
- +6 more
- Anastrozole
- +2 more
-
Fullerton, California
- +8 more
Sep 19, 2022
Pulmonary Arterial Hypertension Trial in United States (Anastrozole, Placebo Oral Tablet)
Active, not recruiting
- Pulmonary Arterial Hypertension
- Anastrozole
- Placebo Oral Tablet
-
Stanford, California
- +6 more
Dec 3, 2021
Short Stature Trial in Palo Alto (Letrozole, Anastrozole)
Completed
- Short Stature
- Letrozole
- Anastrozole
-
Palo Alto, CaliforniaLucile Packard Children's Hospital
Jun 24, 2021
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +21 more
- Anastrozole
- Letrozole
-
Scottsdale, Arizona
- +2 more
May 31, 2022
Blood Vessel Function in Postmenopausal Women With Breast Cancer
Active, not recruiting
- Breast Cancer
- anastrozole
- +3 more
-
Rochester, MinnesotaMayo Clinic
Jan 17, 2023
Breast Cancer Trial in Madison (drug, device, other)
Not yet recruiting
- Breast Cancer
- 18F-fluorofuranylnorprogesterone
- +4 more
-
Madison, WisconsinUW Carbone Cancer Center
Oct 11, 2023
Male Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma Trial in Boston
Not yet recruiting
- Male Breast Cancer
- +2 more
- Tamoxifen
- +3 more
-
Boston, Massachusetts
- +1 more
Aug 12, 2022
Breast Cancer Trial in Baltimore (Anastrozole, Letrozole)
Recruiting
- Breast Cancer
- Anastrozole
- Letrozole
-
Baltimore, MarylandUniversity of Maryland Greenebaum Cancer Center
Apr 29, 2022
Breast Cancer, Breast Tumors Trial in United States (Bevacizumab, Anastrozole, Fulvestrant)
Completed
- Breast Cancer
- Breast Neoplasms
- Bevacizumab
- +2 more
-
Fort Myers, Florida
- +10 more
Nov 16, 2021
Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)
Not yet recruiting
- Breast Cancer, Early Breast Cancer
- Camizestrant
- +4 more
- (no location specified)
Mar 7, 2023
DCIS Trial in Orange (Anastrozole)
Completed
- DCIS
- Anastrozole
-
Orange, CaliforniaChao Family Comprehensive Cancer Center
Apr 19, 2021
Breast Cancer, Cancer Trial in Worldwide (Nivolumab, Anastrozole, Palbociclib)
Completed
- Breast Cancer
- Cancer
- Nivolumab
- +2 more
-
Whittier, California
- +35 more
Jul 14, 2022
Breast Tumors Trial in Mönchengladbach (drug, diagnostic test, procedure)
Active, not recruiting
- Breast Neoplasms
- Perjeta Injectable Product
- +13 more
-
Mönchengladbach, GermanyEvangelisches Krankenhaus Bethesda Mönchengladbach
Oct 4, 2022
Breast Cancer, Cancer of the Breast Trial in Saint Louis (VENTANA MIB-1 Ki67 assay, Oncotype DX® Recurrence Score, PAM50-based
Not yet recruiting
- Breast Cancer
- Cancer of the Breast
- VENTANA MIB-1 Ki67 assay
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Apr 18, 2023
Estrogen Receptor-positive Breast Cancer, Musculoskeletal Complications, Progesterone Receptor-positive Breast Cancer Trial in
Active, not recruiting
- Estrogen Receptor-positive Breast Cancer
- +9 more
- anastrozole
- +3 more
-
Boston, Massachusetts
- +1 more
Sep 9, 2022
Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)
Not yet recruiting
- Breast Cancer, Early Breast Cancer
- Camizestrant
- +5 more
- (no location specified)
Jul 11, 2023
Breast Tumors, Breast Diseases Trial in New York (Anastrozole, Palbociclib, Trastuzumab)
Recruiting
- Breast Neoplasms
- Breast Diseases
- Anastrozole
- +3 more
-
New York, New York
- +4 more
Jun 25, 2021
Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,
Not yet recruiting
- Breast Cancer
- +2 more
- Abemaciclib
- +5 more
-
Boston, Massachusetts
- +7 more
Aug 14, 2023